广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2014年
12期
1688-1691
,共4页
韦家智%任欣欣%尹友生%覃源%马文锋
韋傢智%任訢訢%尹友生%覃源%馬文鋒
위가지%임흔흔%윤우생%담원%마문봉
肾脏缺血%肾灌注损伤%重组人促红细胞生成素%最佳剂量%最佳时机
腎髒缺血%腎灌註損傷%重組人促紅細胞生成素%最佳劑量%最佳時機
신장결혈%신관주손상%중조인촉홍세포생성소%최가제량%최가시궤
Renal ischemia%Renal perfusion injury%Recombinant human erythropoietin%Optimal dosing%Optimal timing
目的:探讨重组人促红细胞生成素( rHuEPO )治疗大鼠肾脏缺血再灌注性损伤的最佳剂量及时机。方法将60只SD大鼠随机分为6组,每组10只,假手术组、模型组、高剂量24(高24)组:造模后腹腔注射rHuEPO 5000 U/kg,24 h后取肾标本;低剂量24(低24)组:rHuEPO 2500 U/kg,24 h取肾脏标本;高剂量48(高48)组:rHuEPO 5000 U/kg,48 h取肾标本;低剂量48(低48)组:rHuEPO 2500 U/kg,24 h后追加2500 U/kg,48 h取肾标本。检测血清尿素氮(BUN)、肌酐水平(Scr)、肾组织中磷酸化应激活化蛋白激酶(p-JNK)的表达及肾小管上皮细胞凋亡情况。结果与假手术组相比,其他5组大鼠BUN、Scr明显升高,凋亡加重,p-JNK表达增多;与模型组相比,各rHuEPO治疗组肾功能明显好转,肾功能高24组好于低24组,高48组好于低48组(P<0.05)。结论及时一次大剂量应用rHuEPO对大鼠肾脏具有更好的保护作用,可能是通过调节p-JNK等因子表达以减少凋亡的发生,而达到改善肾脏病理性损伤。
目的:探討重組人促紅細胞生成素( rHuEPO )治療大鼠腎髒缺血再灌註性損傷的最佳劑量及時機。方法將60隻SD大鼠隨機分為6組,每組10隻,假手術組、模型組、高劑量24(高24)組:造模後腹腔註射rHuEPO 5000 U/kg,24 h後取腎標本;低劑量24(低24)組:rHuEPO 2500 U/kg,24 h取腎髒標本;高劑量48(高48)組:rHuEPO 5000 U/kg,48 h取腎標本;低劑量48(低48)組:rHuEPO 2500 U/kg,24 h後追加2500 U/kg,48 h取腎標本。檢測血清尿素氮(BUN)、肌酐水平(Scr)、腎組織中燐痠化應激活化蛋白激酶(p-JNK)的錶達及腎小管上皮細胞凋亡情況。結果與假手術組相比,其他5組大鼠BUN、Scr明顯升高,凋亡加重,p-JNK錶達增多;與模型組相比,各rHuEPO治療組腎功能明顯好轉,腎功能高24組好于低24組,高48組好于低48組(P<0.05)。結論及時一次大劑量應用rHuEPO對大鼠腎髒具有更好的保護作用,可能是通過調節p-JNK等因子錶達以減少凋亡的髮生,而達到改善腎髒病理性損傷。
목적:탐토중조인촉홍세포생성소( rHuEPO )치료대서신장결혈재관주성손상적최가제량급시궤。방법장60지SD대서수궤분위6조,매조10지,가수술조、모형조、고제량24(고24)조:조모후복강주사rHuEPO 5000 U/kg,24 h후취신표본;저제량24(저24)조:rHuEPO 2500 U/kg,24 h취신장표본;고제량48(고48)조:rHuEPO 5000 U/kg,48 h취신표본;저제량48(저48)조:rHuEPO 2500 U/kg,24 h후추가2500 U/kg,48 h취신표본。검측혈청뇨소담(BUN)、기항수평(Scr)、신조직중린산화응격활화단백격매(p-JNK)적표체급신소관상피세포조망정황。결과여가수술조상비,기타5조대서BUN、Scr명현승고,조망가중,p-JNK표체증다;여모형조상비,각rHuEPO치료조신공능명현호전,신공능고24조호우저24조,고48조호우저48조(P<0.05)。결론급시일차대제량응용rHuEPO대대서신장구유경호적보호작용,가능시통과조절p-JNK등인자표체이감소조망적발생,이체도개선신장병이성손상。
Objective To explore the optimal dosing and timing of recombinant human erythropoietin ( rHuEPO) for the treatment of renal ischemia-reperfusion injury in rats .Methods Sixty SD rats were randomly divided into six groups ,with 10 rats in each group ,including sham operation group ,ischemia reperfusion injury group ( model group ) , high-dose 24 group,low-dose 24 group,high-dose 48 group,and low-dose 48 group.The rats in the high-dose 24 group received the injection of rHuEPO at a dose of 5000 U/kg and then renal specimen sampling 24 hours later.The rats in the low-dose 24 group received the injection of rHuEPO at a dose of 2 500 U/kg and then renal specimen sampling 24 hours later .The rats in the high-dose 48 group received the injection of rHuEPO at a dose of 5 000 U/kg and then renal specimen sampling 48 hours later .The rats in the low-dose 48 group received the injection of rHuEPO at a dose of 2 500 U/kg,and then were give an additional injection of rHuEPO at a dose of 2500 U/kg 24 hours later,followed by the renal specimen sampling 48 hours later.To detect the levels of blood urea nitrogen (BUN) and serum creatinine (Scr),the expression of phosphorylated c-Jun N-terminal kinase(p-JNK) in the kidney tissues and the renal tubular cell apoptosis .Results Compared with sham group ,the rats in other 5 groups showed the significantly higher levels of BUN and Scr ,apoptosis increased ,and p-JNK expression increased .Compared with model group ,the rats in the other groups with rHuEPO therapy showed a significant improvment of renal function .The renal function of rats in the high-dose 24 group was superior to that in the low-dose 24 group,and the renal function of rats in the high-dose 48 group was superior to that in the low-dose 48 group(P<0.05).Conclusion The timely and sufficient large-dose of rHuEPO has a protective effect on rats′kidney, which might contribute to the improvement of renal pathological injury by regulating the p-JNK expression and decreasing the apoptosis .